InsidersTradesSigma
Follow the Zydus Lifesciences share price and the full management transaction log of the company, a listed issuer based in India. Shares are quoted on the IN market, under the authority of SEBI (PIT + SAST). Market capitalisation: €1,117.2bn. The latest transaction was reported on 24 August 2026 (Acquisition). Among the most active insiders: Prashant Babubhai Patel. Every trade is free.
17
Insider Decl.
n/a
Thresholds
n/a
2 ops.
Buy Volume
€74m
15 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Zydus Lifesciences Hold (neutral), based on 30 analysts. Average price target: ₹1,195.78.
24Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 8,965 of 29,063 companies
61.1
score / 100
Value44
Quality78
FCF yld-0.5%
Earn yld4.4%
EV/EBITDA15.3x
ROE18%
Gross mgn71%
Net mgn19%
Debt/EBITDA1.5x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 24 August 2026
Declarations17 total
32,577 shares0EquityOthersSEBI:ea9dcefd02e0bee760acd00e68263e8012946eb3
Canonical exit: 22 Nov 2026 (T+90)
124 shares@ ₹1,260.000.0000% mcap100.0% of flowEquity SharesBuy BackSEBI:34d20d20e4c9bf7e74149f6c8758127af28adbea
248 shares@ ₹1,260.000.0000% mcap100.0% of flowEquity SharesBuy BackSEBI:db712618e07e87493e477182f05c8355765ec8f1
149 shares@ ₹12,600.300.0002% mcap100.0% of flowEquity SharesBuy BackSEBI:2f1220dd9daf5502f95858f35e7d4f6df835232b
124 shares@ ₹1,260.000.0000% mcap100.0% of flowEquity SharesBuy BackSEBI:9bdda33dd5c85e0b47e545ef1b62c34649747792
124 shares@ ₹1,260.000.0000% mcap100.0% of flowEquity SharesBuy BackSEBI:b7617fc62a06f22f7ad66f477aba4e7d13de51c7
98 shares@ ₹1,260.000.0000% mcap100.0% of flowEquity SharesBuy BackSEBI:a888fbabd52adbb808233e2d7ebf095fc2aca0e4
5 shares@ ₹1,260.000.0000% mcap100.0% of flowEquity SharesBuy BackSEBI:bd30e51b483f0d1e66e9174d728559579e7048fe
109 shares@ ₹1,260.000.0000% mcap100.0% of flowEquity SharesBuy BackSEBI:9adab773e88279a958584d9a4dc86e65f6f97e7a
124 shares@ ₹1,260.000.0000% mcap100.0% of flowEquity SharesBuy BackSEBI:efc316965d351e329558c9ccdbf409f8a3e34a65
124 shares@ ₹1,260.000.0000% mcap100.0% of flowEquity SharesBuy BackSEBI:36e40d0d03bc2896d6674d30654fd7ce1adf1174
124 shares@ ₹1,260.000.0000% mcap100.0% of flowEquity SharesBuy BackSEBI:3f3020546a82a2915f7b58b1e1ae2d1ad93606a0
73 shares@ ₹1,260.000.0000% mcap100.0% of flowEquity SharesBuy BackSEBI:25a80295588a7d5a13fa7bc933e5b26d77aa422e
209 shares@ ₹1,260.000.0000% mcap100.0% of flowEquity SharesBuy BackSEBI:3af32b44353453abd1342cc38d073ce273d98784
6,349,542 shares@ ₹1,260.000.74% mcap100.0% of flowEquity SharesBuy BackSEBI:118a730cb372a1a2c0bf3effba1bea74f078064c
640 shares@ ₹1,260.000.0001% mcap100.0% of flowEquity SharesBuy BackSEBI:04aa948938aee392aab8cbeefb3ceea1e084d4f2
10,000 shares0Equity SharesOff MarketSEBI:3177fd2efbc1476513435085ac9c7935208f2e06
Canonical exit: 24 Aug 2026 (T+90)
17 of 17 declarations
关于 Zydus Lifesciences
Zydus Lifesciences 是一家印度制药公司，专注于仿制药和生物制药产品的研究、开发和制造。该公司在孟买证券交易所上市。